Radiation‐induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation
- 4 September 2019
- journal article
- research article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 64 (1) , 113-119
Abstract
Aim: The aim of this study was to determine dosimetric factors, such as mean dose and oesophageal length, which may influence the incidence and severity of oesophagitis in breast cancer patients receiving radiotherapy to the supraclavicular nodes.Methods: This was a single‐arm prospective observational study. Toxicity grading was undertaken twice weekly to determine the onset of grade 2 oesophagitis in consecutive patients prescribed IMRT to the breast or chest wall and supraclavicular fossa (SCF) nodes. Recorded variables included mean and maximum doses to the oesophagus, oesophageal length and pharynx length within the treatment area. Multivariate logistic regression and Fishers’ exact test were used with a 0.05 significance level to compare the onset of grade 2 oesophagitis with these variables.Results: A total of 77 patients were included in the study. Twenty‐four (31%) patients reported grade 2 oesophagitis. There was a higher incidence of grade 2 oesophagitis in patients receiving a mean oesophageal dose of ≥31 Gy compared to those receiving < 31 Gy (18/24 versus 6/24, respectively, P = 0.025). There was a significant difference in the onset of grade 2 toxicity in patients who had ≥ 1 cm of pharynx included in SCF fields compared with those with P = 0.0116). The odds ratios for developing grade 2 oesophagitis were 3.2 (95% CI = 1.05–9.62, P = 0.04) for a mean dose of ≥31 Gy and 3.4 (95% CI = 1.19–9.5, P = 0.022) for ≥1 cm of pharynx in the SCF field.Conclusion: By limiting the mean dose to the irradiated oesophagus to <31 Gy during the planning process and ensuring that <1 cm of pharynx is included in the radiation field, oesophageal toxicity may be minimised.Keywords
This publication has 23 references indexed in Scilit:
- Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial PlexusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Esophagus in-field: A new predictor for esophagitisRadiotherapy and Oncology, 2010
- Radiation Dose-Volume Effects in the EsophagusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Effects of radiation therapy on oesophageal transit in patients with inner quadrant breast tumourNuclear Medicine Communications, 2005
- Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Dosimetric and clinical predictors for radiation-induced esophageal injuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patientsEuropean Journal of Cancer, 2003
- The radiotherapeutic injury – a complex ‘wound’Radiotherapy and Oncology, 2002
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995